SEC Form 4 · accession 0001418215-15-000002
SILICON LABORATORIES INC. · SLAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William G Bock
Officer — President · Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 23, 2015 · 9:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Mar 20, 2015 | M | 10,000 | $31.96 | A | 89,030 | D | |
| Common Stock, $0.0001 par valueF1,F2 | Mar 20, 2015 | S | 10,000 | $52.5001 | D | 79,030 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4,F3 | $31.96 | Mar 20, 2015 | M | 10,000 | D | Feb 15, 2009 | Feb 15, 2018 | Common Stock, $0.0001 par value | 10,000 | 11,250 | D |
Explanation of responses
- F1Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
- F2Price represents the weighted average selling price. Prices range between $52.50 and $52.51 per share.
- F3Option vests and becomes exercisable with respect to (i) twenty-five percent (25%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of thirty-six (36) successive monthly installments from the date exercisable.
- F4Not applicable per instruction 4(c)(iii).